世界のフィブリン分解産物（FnDP）アッセイ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Fibrin Degradation Product (FnDP) Assays Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4224 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、フィブリン分解産物（FnDP）アッセイの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血漿、血清）、用途別市場規模（病院、専門クリニック、診断研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・フィブリン分解産物（FnDP）アッセイの市場動向 ・企業の競争状況、市場シェア ・フィブリン分解産物（FnDP）アッセイの種類別市場規模と予測2016-2027（血漿、血清） ・フィブリン分解産物（FnDP）アッセイの用途別市場規模と予測2016-2027（病院、専門クリニック、診断研究所、その他） ・フィブリン分解産物（FnDP）アッセイの北米市場規模2016-2027（アメリカ、カナダ） ・フィブリン分解産物（FnDP）アッセイの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・フィブリン分解産物（FnDP）アッセイのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・フィブリン分解産物（FnDP）アッセイの中南米市場規模2016-2027（メキシコ、ブラジル） ・フィブリン分解産物（FnDP）アッセイの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sekisui Diagnostics (Sekisui Chemical)、Randox Laboratories、Beckman Coulter Inc. (Danaher Corporation)、Kamiya Biomedical Company、ADALTIS S.r.l.、SDIX, LLC、Lab Mark A.s.、Abbott Laboratories、IBL International (Tecan Group Ltd.)、Analytik Jena AG） ・結論

Market Analysis and Insights: Global Fibrin Degradation Product (FnDP) Assays Market
The global Fibrin Degradation Product (FnDP) Assays market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fibrin Degradation Product (FnDP) Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fibrin Degradation Product (FnDP) Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fibrin Degradation Product (FnDP) Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fibrin Degradation Product (FnDP) Assays market.

Global Fibrin Degradation Product (FnDP) Assays Scope and Market Size
Fibrin Degradation Product (FnDP) Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibrin Degradation Product (FnDP) Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Plasma
Serum

Segment by Application
Hospital
Specialty Clinics
Diagnostic Laboratory
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sekisui Diagnostics (Sekisui Chemical)
Randox Laboratories
Beckman Coulter Inc. (Danaher Corporation)
Kamiya Biomedical Company
ADALTIS S.r.l.
SDIX, LLC
Lab Mark A.s.
Abbott Laboratories
IBL International (Tecan Group Ltd.)
Analytik Jena AG

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fibrin Degradation Product (FnDP) Assays Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Plasma
1.2.3 Serum
1.3 Market by Application
1.3.1 Global Fibrin Degradation Product (FnDP) Assays Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinics
1.3.4 Diagnostic Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Fibrin Degradation Product (FnDP) Assays Market Perspective (2016-2027)
2.2 Fibrin Degradation Product (FnDP) Assays Growth Trends by Regions
2.2.1 Fibrin Degradation Product (FnDP) Assays Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Fibrin Degradation Product (FnDP) Assays Historic Market Share by Regions (2016-2021)
2.2.3 Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Regions (2022-2027)
2.3 Fibrin Degradation Product (FnDP) Assays Industry Dynamic
2.3.1 Fibrin Degradation Product (FnDP) Assays Market Trends
2.3.2 Fibrin Degradation Product (FnDP) Assays Market Drivers
2.3.3 Fibrin Degradation Product (FnDP) Assays Market Challenges
2.3.4 Fibrin Degradation Product (FnDP) Assays Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Fibrin Degradation Product (FnDP) Assays Players by Revenue
3.1.1 Global Top Fibrin Degradation Product (FnDP) Assays Players by Revenue (2016-2021)
3.1.2 Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Players (2016-2021)
3.2 Global Fibrin Degradation Product (FnDP) Assays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Fibrin Degradation Product (FnDP) Assays Revenue
3.4 Global Fibrin Degradation Product (FnDP) Assays Market Concentration Ratio
3.4.1 Global Fibrin Degradation Product (FnDP) Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fibrin Degradation Product (FnDP) Assays Revenue in 2020
3.5 Fibrin Degradation Product (FnDP) Assays Key Players Head office and Area Served
3.6 Key Players Fibrin Degradation Product (FnDP) Assays Product Solution and Service
3.7 Date of Enter into Fibrin Degradation Product (FnDP) Assays Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Fibrin Degradation Product (FnDP) Assays Breakdown Data by Type
4.1 Global Fibrin Degradation Product (FnDP) Assays Historic Market Size by Type (2016-2021)
4.2 Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Type (2022-2027)

5 Fibrin Degradation Product (FnDP) Assays Breakdown Data by Application
5.1 Global Fibrin Degradation Product (FnDP) Assays Historic Market Size by Application (2016-2021)
5.2 Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027)
6.2 North America Fibrin Degradation Product (FnDP) Assays Market Size by Type
6.2.1 North America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021)
6.2.2 North America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027)
6.2.3 North America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2027)
6.3 North America Fibrin Degradation Product (FnDP) Assays Market Size by Application
6.3.1 North America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021)
6.3.2 North America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027)
6.3.3 North America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2027)
6.4 North America Fibrin Degradation Product (FnDP) Assays Market Size by Country
6.4.1 North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021)
6.4.2 North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027)
7.2 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Type
7.2.1 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021)
7.2.2 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027)
7.2.3 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2027)
7.3 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Application
7.3.1 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021)
7.3.2 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027)
7.3.3 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2027)
7.4 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country
7.4.1 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021)
7.4.2 Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027)
8.2 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Type
8.2.1 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2027)
8.3 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Application
8.3.1 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2027)
8.4 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region
8.4.1 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027)
9.2 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Type
9.2.1 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021)
9.2.2 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027)
9.2.3 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2027)
9.3 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Application
9.3.1 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021)
9.3.2 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027)
9.3.3 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2027)
9.4 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country
9.4.1 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021)
9.4.2 Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size (2016-2027)
10.2 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Type
10.2.1 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2027)
10.3 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Application
10.3.1 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2027)
10.4 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country
10.4.1 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sekisui Diagnostics (Sekisui Chemical)
11.1.1 Sekisui Diagnostics (Sekisui Chemical) Company Details
11.1.2 Sekisui Diagnostics (Sekisui Chemical) Business Overview
11.1.3 Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Introduction
11.1.4 Sekisui Diagnostics (Sekisui Chemical) Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.1.5 Sekisui Diagnostics (Sekisui Chemical) Recent Development
11.2 Randox Laboratories
11.2.1 Randox Laboratories Company Details
11.2.2 Randox Laboratories Business Overview
11.2.3 Randox Laboratories Fibrin Degradation Product (FnDP) Assays Introduction
11.2.4 Randox Laboratories Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.2.5 Randox Laboratories Recent Development
11.3 Beckman Coulter Inc. (Danaher Corporation)
11.3.1 Beckman Coulter Inc. (Danaher Corporation) Company Details
11.3.2 Beckman Coulter Inc. (Danaher Corporation) Business Overview
11.3.3 Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Introduction
11.3.4 Beckman Coulter Inc. (Danaher Corporation) Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.3.5 Beckman Coulter Inc. (Danaher Corporation) Recent Development
11.4 Kamiya Biomedical Company
11.4.1 Kamiya Biomedical Company Company Details
11.4.2 Kamiya Biomedical Company Business Overview
11.4.3 Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Introduction
11.4.4 Kamiya Biomedical Company Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.4.5 Kamiya Biomedical Company Recent Development
11.5 ADALTIS S.r.l.
11.5.1 ADALTIS S.r.l. Company Details
11.5.2 ADALTIS S.r.l. Business Overview
11.5.3 ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Introduction
11.5.4 ADALTIS S.r.l. Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.5.5 ADALTIS S.r.l. Recent Development
11.6 SDIX, LLC
11.6.1 SDIX, LLC Company Details
11.6.2 SDIX, LLC Business Overview
11.6.3 SDIX, LLC Fibrin Degradation Product (FnDP) Assays Introduction
11.6.4 SDIX, LLC Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.6.5 SDIX, LLC Recent Development
11.7 Lab Mark A.s.
11.7.1 Lab Mark A.s. Company Details
11.7.2 Lab Mark A.s. Business Overview
11.7.3 Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Introduction
11.7.4 Lab Mark A.s. Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.7.5 Lab Mark A.s. Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Fibrin Degradation Product (FnDP) Assays Introduction
11.8.4 Abbott Laboratories Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 IBL International (Tecan Group Ltd.)
11.9.1 IBL International (Tecan Group Ltd.) Company Details
11.9.2 IBL International (Tecan Group Ltd.) Business Overview
11.9.3 IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Introduction
11.9.4 IBL International (Tecan Group Ltd.) Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.9.5 IBL International (Tecan Group Ltd.) Recent Development
11.10 Analytik Jena AG
11.10.1 Analytik Jena AG Company Details
11.10.2 Analytik Jena AG Business Overview
11.10.3 Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Introduction
11.10.4 Analytik Jena AG Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
11.10.5 Analytik Jena AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Fibrin Degradation Product (FnDP) Assays Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Plasma
Table 3. Key Players of Serum
Table 4. Global Fibrin Degradation Product (FnDP) Assays Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Fibrin Degradation Product (FnDP) Assays Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Fibrin Degradation Product (FnDP) Assays Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Fibrin Degradation Product (FnDP) Assays Market Share by Regions (2016-2021)
Table 8. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Fibrin Degradation Product (FnDP) Assays Market Share by Regions (2022-2027)
Table 10. Fibrin Degradation Product (FnDP) Assays Market Trends
Table 11. Fibrin Degradation Product (FnDP) Assays Market Drivers
Table 12. Fibrin Degradation Product (FnDP) Assays Market Challenges
Table 13. Fibrin Degradation Product (FnDP) Assays Market Restraints
Table 14. Global Fibrin Degradation Product (FnDP) Assays Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Fibrin Degradation Product (FnDP) Assays Market Share by Players (2016-2021)
Table 16. Global Top Fibrin Degradation Product (FnDP) Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibrin Degradation Product (FnDP) Assays as of 2020)
Table 17. Ranking of Global Top Fibrin Degradation Product (FnDP) Assays Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Fibrin Degradation Product (FnDP) Assays Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Fibrin Degradation Product (FnDP) Assays Product Solution and Service
Table 21. Date of Enter into Fibrin Degradation Product (FnDP) Assays Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Type (2016-2021)
Table 25. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Fibrin Degradation Product (FnDP) Assays Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Application (2016-2021)
Table 29. Global Fibrin Degradation Product (FnDP) Assays Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sekisui Diagnostics (Sekisui Chemical) Company Details
Table 62. Sekisui Diagnostics (Sekisui Chemical) Business Overview
Table 63. Sekisui Diagnostics (Sekisui Chemical) Fibrin Degradation Product (FnDP) Assays Product
Table 64. Sekisui Diagnostics (Sekisui Chemical) Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 65. Sekisui Diagnostics (Sekisui Chemical) Recent Development
Table 66. Randox Laboratories Company Details
Table 67. Randox Laboratories Business Overview
Table 68. Randox Laboratories Fibrin Degradation Product (FnDP) Assays Product
Table 69. Randox Laboratories Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 70. Randox Laboratories Recent Development
Table 71. Beckman Coulter Inc. (Danaher Corporation) Company Details
Table 72. Beckman Coulter Inc. (Danaher Corporation) Business Overview
Table 73. Beckman Coulter Inc. (Danaher Corporation) Fibrin Degradation Product (FnDP) Assays Product
Table 74. Beckman Coulter Inc. (Danaher Corporation) Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 75. Beckman Coulter Inc. (Danaher Corporation) Recent Development
Table 76. Kamiya Biomedical Company Company Details
Table 77. Kamiya Biomedical Company Business Overview
Table 78. Kamiya Biomedical Company Fibrin Degradation Product (FnDP) Assays Product
Table 79. Kamiya Biomedical Company Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 80. Kamiya Biomedical Company Recent Development
Table 81. ADALTIS S.r.l. Company Details
Table 82. ADALTIS S.r.l. Business Overview
Table 83. ADALTIS S.r.l. Fibrin Degradation Product (FnDP) Assays Product
Table 84. ADALTIS S.r.l. Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 85. ADALTIS S.r.l. Recent Development
Table 86. SDIX, LLC Company Details
Table 87. SDIX, LLC Business Overview
Table 88. SDIX, LLC Fibrin Degradation Product (FnDP) Assays Product
Table 89. SDIX, LLC Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 90. SDIX, LLC Recent Development
Table 91. Lab Mark A.s. Company Details
Table 92. Lab Mark A.s. Business Overview
Table 93. Lab Mark A.s. Fibrin Degradation Product (FnDP) Assays Product
Table 94. Lab Mark A.s. Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 95. Lab Mark A.s. Recent Development
Table 96. Abbott Laboratories Company Details
Table 97. Abbott Laboratories Business Overview
Table 98. Abbott Laboratories Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 99. Abbott Laboratories Recent Development
Table 100. IBL International (Tecan Group Ltd.) Company Details
Table 101. IBL International (Tecan Group Ltd.) Business Overview
Table 102. IBL International (Tecan Group Ltd.) Fibrin Degradation Product (FnDP) Assays Product
Table 103. IBL International (Tecan Group Ltd.) Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 104. IBL International (Tecan Group Ltd.) Recent Development
Table 105. Analytik Jena AG Company Details
Table 106. Analytik Jena AG Business Overview
Table 107. Analytik Jena AG Fibrin Degradation Product (FnDP) Assays Product
Table 108. Analytik Jena AG Revenue in Fibrin Degradation Product (FnDP) Assays Business (2016-2021) & (US$ Million)
Table 109. Analytik Jena AG Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fibrin Degradation Product (FnDP) Assays Market Share by Type: 2020 VS 2027
Figure 2. Plasma Features
Figure 3. Serum Features
Figure 4. Global Fibrin Degradation Product (FnDP) Assays Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinics Case Studies
Figure 7. Diagnostic Laboratory Case Studies
Figure 8. Others Case Studies
Figure 9. Fibrin Degradation Product (FnDP) Assays Report Years Considered
Figure 10. Global Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Fibrin Degradation Product (FnDP) Assays Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Fibrin Degradation Product (FnDP) Assays Market Share by Regions: 2020 VS 2027
Figure 13. Global Fibrin Degradation Product (FnDP) Assays Market Share by Regions (2022-2027)
Figure 14. Global Fibrin Degradation Product (FnDP) Assays Market Share by Players in 2020
Figure 15. Global Top Fibrin Degradation Product (FnDP) Assays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Fibrin Degradation Product (FnDP) Assays as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Fibrin Degradation Product (FnDP) Assays Revenue in 2020
Figure 17. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Type (2016-2021)
Figure 18. Global Fibrin Degradation Product (FnDP) Assays Revenue Market Share by Type (2022-2027)
Figure 19. North America Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Fibrin Degradation Product (FnDP) Assays Market Share by Type (2016-2027)
Figure 21. North America Fibrin Degradation Product (FnDP) Assays Market Share by Application (2016-2027)
Figure 22. North America Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027)
Figure 23. United States Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Fibrin Degradation Product (FnDP) Assays Market Share by Type (2016-2027)
Figure 27. Europe Fibrin Degradation Product (FnDP) Assays Market Share by Application (2016-2027)
Figure 28. Europe Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027)
Figure 29. Germany Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Fibrin Degradation Product (FnDP) Assays Market Share by Region (2016-2027)
Figure 39. China Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Fibrin Degradation Product (FnDP) Assays Market Share by Type (2016-2027)
Figure 47. Latin America Fibrin Degradation Product (FnDP) Assays Market Share by Application (2016-2027)
Figure 48. Latin America Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027)
Figure 49. Mexico Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Fibrin Degradation Product (FnDP) Assays Market Share by Country (2016-2027)
Figure 55. Turkey Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Fibrin Degradation Product (FnDP) Assays Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sekisui Diagnostics (Sekisui Chemical) Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 59. Randox Laboratories Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 60. Beckman Coulter Inc. (Danaher Corporation) Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 61. Kamiya Biomedical Company Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 62. ADALTIS S.r.l. Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 63. SDIX, LLC Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 64. Lab Mark A.s. Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 66. IBL International (Tecan Group Ltd.) Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 67. Analytik Jena AG Revenue Growth Rate in Fibrin Degradation Product (FnDP) Assays Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---